Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 480,733 |
|
|||||
| News | - | ||||||
| Day High | 1.11 | Low High |
|||||
| Day Low | 1.04 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| SELLAS Life Sciences Group Inc | SLS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.05 | 4.81% | 1.09 | 19:36:50 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.06 | 1.04 | 1.11 | 1.08 | 1.04 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,159 | 480,733 | $ 1.07 | $ 512,494 | - | 0.8089 - 4.13 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:59:53 | 5 | $ 1.0895 | USD |
SELLAS Life Sciences Group Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 34.31M | 32.06M | - | 1M | -41.3M | -1.29 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
SELLAS Life Sciences News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SLS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.00 | 1.31 | 0.99 | 1.04 | 997,641 | 0.09 | 9.0% |
| 1 Month | 0.95 | 1.31 | 0.8089 | 0.9760172 | 859,178 | 0.14 | 14.74% |
| 3 Months | 1.48 | 1.90 | 0.8089 | 1.11 | 635,683 | -0.39 | -26.35% |
| 6 Months | 1.71 | 1.914 | 0.8089 | 1.20 | 362,150 | -0.62 | -36.26% |
| 1 Year | 2.42 | 4.13 | 0.8089 | 1.54 | 338,435 | -1.33 | -54.96% |
| 3 Years | 3.88 | 19.38 | 0.8089 | 9.33 | 741,632 | -2.79 | -71.91% |
| 5 Years | 1.80 | 19.38 | 0.11 | 2.01 | 2,332,129 | -0.71 | -39.44% |
SELLAS Life Sciences Description
| SELLAS Life Sciences Group Inc is a biopharmaceutical company. The company is engaged in the development of novel cancer immunotherapies for a broad range of cancer indications. Its pipeline products are Galinpepimut-S, Nelipepimut-S, GALE-301/-302 and NeuVax. |
